Objectives: Dialysis patients' nutritional indicators are quite subjective and complex and cannot be easily measured in clinical settings. Based on previous reports that total lymphocyte count (TLC) and subpopulation lymphocyte counts (SLCs) are associated with nutritional status in patients with dialysis, we designed this study to examine the relationships of the TLC and SLCs with clinical outcome and nutritional status in patients undergoing maintenance hemodialysis (HD) and peritoneal dialysis (PD). Methods: In this prospective, observational study, we enrolled 66 patients (50 HD patients and 16 PD patients) receiving stable maintenance dialysis. We evaluated the baseline parameters of height; weight; TLC; SLCs expressing CD3, CD4, CD8 and CD19; CBC; iron profile (iron, TIBC, ferritin); BUN; Cr; Na; K; total CO2; Ca; P; iPTH; protein; albumin; total cholesterol; HDL; LDL; uric acid and CRP and calculated Onodera's prognostic nutritional index (OPNI) and the Geriatric Nutritional Risk Index (GNRI) at baseline and three months. To analyze differences in the TLC and SLCs between the HD group and the PD group, we performed an independent samples t-test. Logistic regression analysis was performed to predict malnutrition in dialysis patients. In addition, to analyze changes in TLC, SLCs expressing each marker (CD3, CD4, CD8 and CD19) and other nutritional markers, we performed general linear model (GLM)-repeated measures ANOVA. Results: Mean age was 55.8 ± 12.7 years in HD paitents and 49.8 ± 14.5 years in PD patients. The duration of dialysis was 59.7 ± 52.9 months in HD patients and 66.1 ± 33.6 years in PD patients. Logistic regression analysis revealed that patients aged 60 years or older, women, and those whose CD19 SLCs were lower than 100 had a higher risk of developing malnutrition. In GLM-repeated measures ANOVA, CD19 SLCs were significantly higher in women and in patients with a shorter period of dialysis. Conclusions: Our results indicate that GNRI, OPNI, TLC and SLCs (especially CD19 count) may be significant nutritional markers in HD and PD patients.
There are many studies showing that nutritional status is an independent auxiliary indicator associated with the prevalence of and mortality from maintenance hemodialysis (HD) and peritoneal dialysis (PD). Various indicators have previously been reported to be associated with nutritional status in patients with maintenance HD and PD.
Some of these indicators are quite subjective, while others are complex, making them difficult to measure in clinical settings.
Recently, Yamada et al. reported that Geriatric
Nutritional Risk Index (GNRI) was a useful tool in assessing the nutritional status in chronic HD patients. 1 Panichi reported that lower GNRI is associated with malnutrition and it is a strong predictor of overall mortality in HD patients and other author reported that GNRI was a simple method for predicting nutritional status and clinical outcomes in PD patients. 2, 3 Onodera et al. first reported the validity of the Onodera's prognostic nutritional index (OPNI) in predicting the prognosis in 189 patients undergoing gastrointestinal surgeries. 4 The equation for the OPNI includes the serum albumin level and the total lymphocyte count (TLC). Moreover, it is a simple method for predicting the nutritional status and clinical outcome of PD patients. 5 It is known that immunological disturbances (e.g., an
increased ratio of Th1/Th2 and reduced B-cell count) occur as a result of conditions such as uremia in patients with end-stage renal disease (ESRD). 6 Recently, it has been shown that TLC and subpopulation lymphocyte counts (SLCs) are useful in monitoring the nutritional status of PD patients. 7 However, there is still controversy regarding the value of TLC as a suitable marker of protein-calorie malnutrition. Nevertheless, TLC has been shown to be helpful in monitoring nutritional status and assessing prognosis in PD patients. 8 Higher SLCs in PD patients are associated with higher clinical-laboratory scores, which indicate more effective PD treatment. 7 Based on previous reports that TLC and SLCs are associated with nutritional status in patients with dialysis, we designed this study to examine the relationships of TLC and SLCs with clinical outcomes and nutritional status in patients undergoing maintenance HD or PD.
MATERIAL AND METHOD
In this prospective, observational study, we enrolled 66 patients (50 HD patients and 16 PD patients) receiving stable maintenance dialysis at Kosin University Gospel Hospital. Their clinical and laboratory data were retrieved from medical records. The current study was approved by the Institutional Review Board (IRB) of Kosin University Gospel Hospital. All the patients submitted a written informed consent.
Inclusion and Exclusion Criteria
(1) Inclusion criteria : Patients who met all the inclusion criteria were eligible for study participation.
(1)- 78.3%, P < 0.05). The cutoff risk point of nutrition for each tool was then defined from the highest sensitivity -(1 -specificity) value in the ROC curve.
3) The OPNI was calculated based on the serum albumin level and TLC, using the following equa- Note that body weight/ideal body weight was greater than 1 when a subject's body weight exceeded his ideal body weight. The ideal body weight was calculated using height and a BMI of 22, which is reportedly associated with the lowest morbidity rate in the Asian population. 10 Values of GNRI < 100 were defined as malnutrition. 
Endpoint
Clinical characteristics of the patients were evaluated at baseline and three months. We there- 
RESULTS
The clinical characteristics of the patients in the HD and PD groups at baseline were summarized (Table 1 ,2). There were no significant differences in age, sex, diabetes mellitus history or period of dialysis, total CO 2 , protein, total cholesterol, HDL, LDL, uric acid, CRP between the two groups. In the HD group, OPNI and potassium and albumin levels were significantly higher than in the PD group (Table 1 ). In the PD group, BMI, dialysis-adequacy and PTH level were significantly higher than in the HD group (Table 1) .
We compared the two groups based on GNRI 100 and found that there was no significant difference in TLC between the two groups at baseline (Table 3 ). In addition, CD3 count at baseline was significantly higher in the group with a GNRI > 100. No other SLCs showed a significant difference between the two groups at baseline, although the values were higher in GNRI > 100 group.
We compared the two groups based on OPNI 45 (Table 4 ). This analysis revealed that TLC and CD3, CD4, CD8 and CD19 SLCs were significantly higher in the group with OPNI > 45 at baseline.
Baseline measurements of GNRI < 100 were defined as malnutrition ( Based on a cut-off value of 100 for CD19 SLCs at baseline, we divided our clinical series of patients into two groups and compared their clinical characteristics (Table 7) . This comparison revealed that the period of dialysis and OPNI were significantly shorter and higher, respectively, in the patients with CD19 SLCs > 100.
We performed GLM-repeated measures ANOVA (Table 9 ).
DISCUSSION
Our results indicate that GNRI, OPNI, TLC and SLCs (particularly CD19 count) may be significant nutritional markers in HD and PD patients.
The present study showed that TLCs were significantly higher in patients with a shorter period of dialysis at both baseline and three months. In addition, CD19 SLCs were significantly higher in patients with a shorter period of dialysis and In order to contain the stable patients in the study, any patients who were diagnosed with cardiovascular disease, gastrointestinal bleeding and neurological disease (e.g., stroke or meningitis)
within the past three months were excluded.
The GNRI is a very simple and objective method based on body weight, height and serum albumin level and is used to assess nutritional status in a number of pathological conditions. Some studies have investigated the reliability of GNRI in assessing malnutrition in chronic HD and PD patients. 1, 3 According to a recent European study, a low GNRI score can be considered a simple and reliable marker of malnutrition and a predictor for mortality risk in Caucasian HD patients. 2 According to another recent study, GNRI is a valid tool for the longitudinal assessment of nutritional status in HD patients. 11 Our previous study also showed similar findings. 12 In the current study, at three months, total cholesterol and BUN, both of which are nutritional indicators, were higher in the group with a higher GNRI at three months. Thus, we confirmed that GNRI is a reliable nutritional indicator. Table 6 . Logistic regression for predicting malnutrition according to OPNI 45 at start of study level and TLC. A simpler tool may involve common measures. It has also recently been shown that OPNI is a simple method for predicting nutritional status in PD patients. 5 In patients undergoing HD, as compared with those undergoing PD, OPNI and TLC were significantly higher. In addition, despite a lack of statistical significance, SLCs were relatively higher (Table 1 ). In particular, in the group with OPNI > 45, both TLC and SLCs were significantly higher.
The equation for OPNI includes serum albumin
Despite a lack of statistical significance, nutritional indicators such as Hb, Kt/V, iron and K also tended to be higher. Thus, we confirmed that OPNI is a reliable nutritional indicator.
Further studies are warranted to examine whether OPNI is a reliable nutritional indicator in a larger cohort of patients undergoing HD.
OPNI validation has not been widely performed in patients with chronic kidney disease,. This may be due to several limitations such as the application of serum albumin level and TLC as variables for OPNI and changes in OPNI based on variable conditions. TLC was significantly higher in patients undergoing HD. Among T-cell populations, although the number of circulating CD3 and CD4 cells was lower and a reduced ratio of CD4 to CD8 cells was observed in our ESRD patients, the differences were not significant ( Table 1) .The depletion of the T-cell population in our study could be ex- Table 7 . Clinical characteristics of 66 dialysis patients according to CD19 count at start of the study plained by the effects of uremia and malnutrition.
Our results are consistent with previous reports that T-lymphocyte populations are significantly reduced in ESRD patients. 6 In patients with ESRD, SLCs have been reported to be lower than those in normal healthy individuals. 13 This is also consistent with our results. The reasons for the reduced SLCs include uremia and anemia. Moreover, malnutrition has also been reported to be one of the major causes of reduced SLCs. 13 In our study; there were significantly decreased number of total B cells (CD 19 cells). In our study, there was a significantly smaller number of total B cells (CD19 cells) in ESRD patients, consistent with a previous report. 6 Malnutrition is asso¬ciated with a reduced CD4:CD8 ratio as well as the appear¬ance of peripheral immature T cells. 14 A reduction in a particular lymphocyte type is typically associated with the level of a specific nutrient (e.g., the known association between β-carotene and CD19). 7 It would be valuable to identify these correlations in order to determine the insufficient nutrients.
In our previous study, we found that TLC may be used as a simple nutritional tool and is marginally correlated with GNRI in HD patients. 15 In ad dition, TLC has been used as a measure of visceral This deserves further investigation in large-scale, prospective, long-term studies.
As shown in Tables 4 and 7 , OPNI is calculated using a formula based on TLCs and leads to the speculation that it reflects changes in SLCs rather than those of GNRI. It can be inferred that OPNI would be more useful than GNRI in evaluating nutritional status in patients undergoing dialysis.
As shown in Tables 5 and 6, we examined whether GNRI, OPNI and/or SLC was more useful in predicting malnutrition compared with other parameters. Our results suggest that both TLC and SLCs are useful indicators for the prediction of malnutrition.
As shown in Tables 8-9 , we performed GLM-repeated measures ANOVA of changes in TLC and SLCs three months from baseline. In addition, we compared various parameters between the two groups. This analysis revealed that a shorter period of dialysis was associated with higher TLC and SLCs, particularly in the CD4 and CD19 subpopulations, indicating that the period of dialysis might have a significant correlation with malnutrition.
There are several limitations of the current study: 
